Clinical trial
A Double-blind, Randomized, Parallel-group, Vehicle-controlled, Multi-center Study to Evaluate the Safety and Clinical Equivalence of a Generic Ciclopirox Olamine Topical Suspension to Reference Ciclopirox Topical Suspension 0.77% in the Treatment of Tinea Pedis
NCT00804193 is registered in ClinicalTrials.gov with Padagis LLC as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Double-blind, Randomized, Parallel-group, Vehicle-controlled, Multi-center Study to Evaluate the Safety and Clinical Equivalence of a Generic Ciclopirox Olamine Topical Suspension to Reference Ciclopirox Topical Suspension 0.77% in the Treatment of Tinea Pedis
- Lead sponsor
- Padagis LLC
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- June 30, 2004
- Completion date
- April 30, 2005
- Enrollment
- 553 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.